Abstract
Lung cancer is the leading cause of cancer-related death worldwide among both men and women. Although advances in therapy have been made, the 5-year survival rates for lung cancer remain poor, ranging from 10% to 20%. One of the main reasons is late presentation, as only 25% of patients are amenable to cure at the time of presentation. Therefore, the emphasis on lung cancer screening (LCS) is growing with the current evidence that has shown benefits with low-dose computed tomography scan of the chest in high-risk populations. LCS remains a debated topic in Gulf Cooperation Council (GCC) countries, possibly due to a lack of local experience. In this article, we explore the rationale and give recommendations on the best approach for LCS in GCC.
Original language | English |
---|---|
Pages (from-to) | 189-192 |
Number of pages | 4 |
Journal | Annals of Thoracic Medicine |
Volume | 17 |
Issue number | 4 |
DOIs | |
Publication status | Published - Jan 1 2022 |
Keywords
- Low-dose computed tomography
- Lung cancer
- Lung cancer screening
ASJC Scopus subject areas
- Surgery
- Pulmonary and Respiratory Medicine
- Cardiology and Cardiovascular Medicine